Context Therapeutics signs second multimilliondollar licensing deal in 3 months
Sep 23, 2024
Context Therapeutics said Monday it has acquired the exclusive worldwide rights to BioAtla Inc.'s new drug candidate.
https://www.bizjournals.com/philadelphia/news/2024/09/23/context-therapeutics-cancer-licensing-deal-bioatla.html?ana=RSS&s=article_search
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service